Protein kinase CK2 interacts with the splicing factor hPrp3p

Oncogene

Volumn 27, Issue 17, 2008, Pages 2390-2400

  Lehnert, S ^a   Gotz C ^a   Kartarius, S ^a   Schafer B ^a   Montenarh, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

hPrp3p; Phosphorylation; Protein kinase CK2; Protein protein interaction; Splicing factor

Indexed keywords

CASEIN KINASE II; HPRP3P SPLICING FACTOR; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; BETA CHAIN; CARBOXY TERMINAL SEQUENCE; EMBRYO; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA PROCESSING; RNA SPLICING; SPLICEOSOME;

AMINO ACID SEQUENCE; CASEIN KINASE II; CATALYTIC DOMAIN; CELL CYCLE; DATABASES, PROTEIN; HELA CELLS; HOLOENZYMES; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; RIBONUCLEOPROTEIN, U4-U6 SMALL NUCLEAR; RNA SPLICING; SPLICEOSOMES;

EID: 42049118391     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210882     Document Type: Article

References (35)

1. Bosc DG, Graham KC, Saulnier RB, Zhang CJ, Prober D, Gietz RD et al. (2000). Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2. J Biol Chem 275: 14295-14306.
2. Burnett G, Kennedy EP. (1954). The enzymatic phosphorylation of proteins. J Biol Chem 211: 969-980.
3. Cabrejos ME, Allende CC, Maldonado E. (2004). Effects of phosphorylation by protein kinase CK2 on the human basal components of the RNA polymerase II transcription machinery. J Cell Biochem 93: 2-10.
4. Chakarova CF, Hims MM, Bolz H, bu-Safieh L, Patel RJ, Papaioannou MG et al. (2002). Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa. Hum Mol Genet 11: 87-92.
5. Faust M, Kartarius S, Schwindling SL, Montenarh M. (2002). Cyclin H is a new binding partner for protein kinase CK2. Biochem Biophys Res Commun 269: 6-12.
6. Faust M, Schuster N, Montenarh M. (1999). Specific binding of protein kinase CK2 catalytic subunits to tubulin. FEBS Lett 462: 51-56.
7. Gonzalez-Santos JM, Wang A, Jones J, Ushida C, Liu J, Hu J. (2002). Central region of the human splicing factor Hprp3p interacts with Hprp4p. J Biol Chem 277: 23764-23772.
8. Götz C, Kartarius S, Schetting S, Montenarh M. (2005). Immunologically defined subclasses of the protein kinase CK2β-subunit in prostate carcinoma cell lines. Mol Cell Biochem 274: 181-187.
9. Grankowski N, Boldyreff B, Issinger O-G. (1991). Isolation and characterization of recombinant human casein kinase II subunits α and β from bacteria. Eur J Biochem 198: 25-30.
10. Guerra B, Götz C, Wagner P, Montenarh M, Issinger O-G. (1997). The carboxy terminus of p53 mimicks the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation. Oncogene 14: 2683-2688.
11. Guerra B, Niefind K, Pinna LA, Schomburg D, Issinger O-G. (1998). Expression, purification and crystallization of the catalytic subunit of protein kinase CK2 from Zea mays. Acta Crystallogr D54: 143-145.
12. Guerra B, Siemer S, Boldyreff B, Issinger OG. (1999). Protein kinase CK2: evidence for a protein kinase CK2β subunit fraction, devoid of the catalytic CK2α subunit, in mouse brain and testicles. FEBS Lett 462: 353-357.
13. Jain N, Mahendran R, Philp R, Guy GR, Tan YH, Cao X. (1996). Casein kinase II associates with Egr-1 and acts as a negative modulator of its DNA binding and transcription activities in NIH 3T3 cells. J Biol Chem 271: 13530-13536.
14. Krempler A, Kartarius S, Günther J, Montenarh M. (2005). Cyclin H is targeted to the nucleus by C-terminal nuclear localization sequences. Cell Mol Life Sci 62: 1379-1387.
15. Kuenzel EA, Krebs EG. (1985). A synthetic peptide substrate specific for casein kinase II. Proc Natl Acad Sci USA 82: 737-741.
16. Li M, Strand D, Krehan A, Pyerin W, Heid H, Neumann B et al. (1999). Casein kinase 2 binds and phosphorylates the nucleosome assembly protein-1 (NAP1) in Drosophila melanogaster. J Mol Biol 293: 1067-1084.
17. Litchfield DW. (2003). Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 369: 1-15.
18. Liu S, Rauhut R, Vornlocher HP, Luhrmann R. (2006). The network of protein-protein interactions within the human U4/U6.U5 tri-snRNP. RNA 12: 1418-1430.
19. Maita H, Kitaura H, Keen TJ, Inglehearn CF, Ariga H, Iguchi-Ariga SM. (2004). PAP-1, the mutated gene underlying the RP9 form of dominant retinitis pigmentosa, is a splicing factor. Exp Cell Res 300: 283-296.
20. Meggio F, Boldyreff B, Issinger O-G, Pinna LA. (1994). Casein kinase 2 down-regulation and activation by polybasic peptides are mediated by acidic residues in the 55-64re gion of the beta-subunit. A study with calmodulin as phosphorylatable substrate. Biochemistry 33: 4336-4342.
21. Meggio F, Pinna LA. (2003). One-thousand-and-one substrates of protein kinase CK2? The FASEB Journal 17: 349-368.
22. Messenger MM, Saulnier RB, Gilchrist AD, Diamond P, Gorbsky GJ, Litchfield DW. (2002). Interactions between protein kinase CK2 and Pin1Evidence for phosphorylation-dependent interactions. J Biol Chem 277: 23054-23064.
23. Palancade B, Dubois MF, Bensaude O. (2002). FCP1 phosphorylation by casein kinase 2 enhances binding to TFIIF and RNA polymerase II carboxyl-terminal domain phosphatase activity. J Biol Chem 277: 36061-36067.
24. Payne JM, Laybourn PJ, Dahmus ME. (1989). The transition of RNA polymerase II from initiation to elongation is associated with phosphorylation of the carboxyl-terminal domain of subunit IIa. J Biol Chem 264: 19621-19629.
25. Penner CG, Wang ZL, Litchfield DW. (1997). Expression and localization of epitope-tagged protein kinase CK2. J Cell Biochem 64: 525-537.
26. Pinna LA. (2002). Protein kinase CK2: a challenge to canons. J Cell Sci 115: 3873-3878.
27. Proudfoot NJ, Furger A, Dye MJ. (2002). Integrating mRNA processing with transcription. Cell 108: 501-512.
28. Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella-Deana A et al. (2001). Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). FEBS Lett 496: 44-48.
29. Schneider E, Kartarius S, Schuster N, Montenarh M. (2002). The cyclin H/cdk7/Mat1 kinase activity is regulated by CK2 phosphorylation of cyclin H. Oncogene 21: 5031-5037.
30. Schneider HR, Issinger O-G. (1988). Nucleolin (C23), a physiological substrate for casein kinase II. Biochem Biophys Res Commun 156: 1390-1397.
31. Schuster N, Prowald A, Schneider E, Scheidtmann K-H, Montenarh M. (1999). Regulation of p53 mediated transactivation by the β-subunit of protein kinase CK2. FEBS Lett 447: 160-166.
32. Shi Y, Brown ED, Walsh CT. (1994). Expression of recombinant human casein kinase II and recombinant heat shock protein 90 in Escherichia coli and characterization of their interactions. Proc Natl Acad Sci USA 91: 2767-2771.
33. Stalter G, Siemer S, Becht E, Ziegler M, Remberger K, Issinger O-G. (1994). Asymmetric expression of protein kinase CK2 in human kidney tumors. Biochem Biophys Res Commun 202: 141-147.
34. Trembley JH, Hu DL, Slaughter CA, Lahti JM, Kidd VJ. (2003). Casein kinase 2 interacts with cyclin-dependent kinase 11 (CDK11) in vivo and phosphorylates both the RNA polymerase II carboxylterminal domain and CDK11 in vitro. J Biol Chem 278: 2265-2270.
35. Trembley JH, Tatsumi S, Sakashita E, Loyer P, Slaughter CA, Suzuki H et al. (2005). Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation. Mol Cell Biol 25: 1446-1457.